Adiponectin is an adipokine that has anti‐steatotic, anti‐inflammatory and anti‐fibrotic effects. The impact of these different activities impact on the development and progression of non‐alcoholic fatty liver disease (NAFLD) is not well understood. The aim of this study was to evaluate both liver and serum adiponectin levels in patients with and without NAFLD and determine any clinical correlations.

中文翻译：

---

非酒精性脂肪肝患者的肝脏和血清脂联素水平

脂联素是一种脂肪因子，具有抗脂肪变性、抗炎和抗纤维化作用。这些不同活动对非酒精性脂肪性肝病 (NAFLD) 的发展和进展的影响尚不清楚。本研究的目的是评估 NAFLD 患者和非 NAFLD 患者的肝脏和血清脂联素水平，并确定任何临床相关性。